Paper Review Records
全部论文审稿周期
10 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期；保留 PDF/DOI/网页源链接
102
天
Selection of isatuximab dosing regimen in pediatric patients with leukemia using population pharmacokinetics
作者
Claire Brillac; Dorothée Sémiond; Corina Oprea; André Baruchel; C. Michel Zwaan; Laurent Nguyen展开收起
作者单位
1. Sanofi Research and Development, Vitry-sur-Seine, France; 2. Sanofi, Cambridge, MA, USA; 3. Robert Debré University Hospital (APHP and Université Paris Cité), Paris, France; 4. Princess Máxima Centre for Pediatric Oncology, Utrecht, The Netherlands, and Department of Pediatric Oncology, Erasmus MC - Sophia Children’s Hospital, Rotterdam, The Netherlands展开收起
107
天
Mechanisms of resistance to antibody-drug conjugates in cancer: molecular barriers and pharmacological solutions
作者
Lina Eltaib; Muhammad Afzal; Chandana Maji; H. Malathi; Kavita Goyal; Haider Ali; Gaurav Gupta; Md Sadique Hussain展开收起
作者单位
1. Department of Pharmaceutics, College of Pharmacy, Northern Border University, Rafha, Saudi Arabia; 2. Department of Pharmaceutical Sciences, Pharmacy Program, Batterjee Medical College, Jeddah, Saudi Arabia; 3. Noida Institute of Engineering and Technology (Pharmacy Institute), Greater, India; 4. Department of Biotechnology and Genetics, School of Sciences, JAIN (Deemed to be University), Bangalore, India; 5. Department of Biotechnology, Graphic Era (Deemed to be University), Clement Town, Dehradun, India; 6. Centre for Global Health Research, Saveetha Institute of Medical and Technical Sciences, Saveetha Medical College, Saveetha University, Chennai, India; 7. Centre for Research Impact & Outcome-Chitkara College of Pharmacy, Chitkara University, Rajpura, India; 8. Centre of Medical and Bio-allied Health Sciences Research, Ajman University, Ajman, UAE; 9. Uttaranchal Institute of Pharmaceutical Sciences, Uttaranchal University, Dehradun, India; 10. School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, India展开收起
132
天
Impact of adverse events on survival outcomes in patients treated with CDK4/6 inhibitors for advanced breast cancer
作者
Martina Catalano; Gestiana Cekrezi; Irene De Gennaro Aquino; Delia Ravizza; Alexandra Paulet; Kristian Shtembari; Claudia De Angelis; Roberto Petrioli; Daniele Generali; Giandomenico Roviello展开收起
作者单位
1. Department of Health Sciences, Clinical Pharmacology and Oncology Section, University of Florence, Florence, Italy; 2. School of Medicine and Surgery, University of Florence, Florence, Italy; 3. Clinical Oncology, Careggi University Hospital, Florence, Italy; 4. Medical Oncology Unit, Careggi University Hospital, Florence, Italy; 5. Unit of Medical Oncology, Department of Medicine, Surgery and Neurosciences, University of Siena, Siena, Italy; 6. Department of Medicine, Surgery and Health Sciences, University of Trieste, Trieste, Italy; 7. Multidisciplinary Unit of Breast Pathology and Translational Research, Cremona Hospital, Cremona, Italy展开收起
152
天
6-gingerol alleviates chemotherapy-induced nausea and vomiting by inhibiting ferroptosis via the regulation of iron homeostasis
作者
Wan Liang; Lei Feng; Siyu Han; Chenglu Yang; Binbin Ye; Ziyao Mo; Ke Nie展开收起
作者单位
1. School of Chinese Materia Medica, Guangdong Pharmaceutical University, Guangzhou, P.R. China展开收起
Expert Matching · Case Demo
把投稿要求，转成可验证的期刊方案
说清专业、时限和作者背景，CrushSCI 结合真实审稿样本，给出拟题方向、期刊初筛与周期判断。
客户询问
我是环境工程专业，需要一篇 SCI，希望 3 个月内见刊。没有基金，也没有大牛挂名，可以投哪些期刊？
CrushSCI回复
可以。先按 90 天时限做可行性筛选，同步查找无基金、无知名作者挂靠的典型论文案例，作为选刊依据。重点核对研究质量与期刊 scope。
- 拟题建议
- 《融合机器学习与生命周期评价的城市污水处理碳排放预测与优化》
样本口径2026 年最近 5 篇有效论文样本
平均审稿62 天
中位数65 天